[go: up one dir, main page]

UA91848C2 - Применение соединений диосметина в лечении и предотвращении тромботическим патологиям - Google Patents

Применение соединений диосметина в лечении и предотвращении тромботическим патологиям

Info

Publication number
UA91848C2
UA91848C2 UAA200710762A UAA200710762A UA91848C2 UA 91848 C2 UA91848 C2 UA 91848C2 UA A200710762 A UAA200710762 A UA A200710762A UA A200710762 A UAA200710762 A UA A200710762A UA 91848 C2 UA91848 C2 UA 91848C2
Authority
UA
Ukraine
Prior art keywords
prevention
treatment
compounds
diosmethine
application
Prior art date
Application number
UAA200710762A
Other languages
English (en)
Ukrainian (uk)
Inventor
Тоне Верберен
Ален Рюпен
Патрисия Сансильвестри-Морель
Мари-Одиль Валле
Мари-Франсуаз Буссар
Мишель Виерзбики
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of UA91848C2 publication Critical patent/UA91848C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Применение соединений диосметина в получении фармацевтических композиций, предназначенных для предотвращения и/или лечения тромботических патологий и патологий с риском тромбоза.
UAA200710762A 2005-03-01 2006-02-28 Применение соединений диосметина в лечении и предотвращении тромботическим патологиям UA91848C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0502044A FR2882654B1 (fr) 2005-03-01 2005-03-01 Utilisation de derives de la diosmetine pour le traitement et la prevention des pathologies thrombotiques

Publications (1)

Publication Number Publication Date
UA91848C2 true UA91848C2 (ru) 2010-09-10

Family

ID=35134198

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200710762A UA91848C2 (ru) 2005-03-01 2006-02-28 Применение соединений диосметина в лечении и предотвращении тромботическим патологиям

Country Status (18)

Country Link
US (1) US20080176934A1 (ru)
EP (1) EP1853253A1 (ru)
JP (1) JP2008531660A (ru)
KR (2) KR20090128581A (ru)
CN (1) CN101132788A (ru)
AR (1) AR053149A1 (ru)
AU (1) AU2006219853B2 (ru)
BR (1) BRPI0607562A2 (ru)
CA (1) CA2599658A1 (ru)
EA (1) EA013078B1 (ru)
FR (1) FR2882654B1 (ru)
MA (1) MA29316B1 (ru)
MX (1) MX2007010364A (ru)
NO (1) NO20074941L (ru)
NZ (1) NZ560749A (ru)
UA (1) UA91848C2 (ru)
WO (1) WO2006092490A1 (ru)
ZA (1) ZA200707472B (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2002835A1 (en) 2007-06-04 2008-12-17 GenKyo Tex Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
FR2929276B1 (fr) * 2008-04-01 2010-04-23 Servier Lab Nouveaux derives de diosmetine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR101162816B1 (ko) * 2008-04-01 2012-07-09 르 라보레또레 쎄르비에르 디오스메틴 화합물，이의 제조 방법 및 이를 함유하는 약제학적 조성물
EP2166009A1 (en) 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as nadph oxidase inhibitors
EP2165707A1 (en) 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
EP2166010A1 (en) 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
WO2010062681A2 (en) * 2008-10-30 2010-06-03 University Of South Florida Luteolin and diosmin/diosmetin as novel stat3 inhibitors for treating autism
EP2305679A1 (en) 2009-09-28 2011-04-06 GenKyoTex SA Pyrazoline dione derivatives as nadph oxidase inhibitors
PL2782598T3 (pl) 2011-11-23 2021-03-08 In3Bio Ltd. Rekombinowane białka i ich zastosowania terapeutyczne
EP3034500A1 (en) 2014-12-17 2016-06-22 Genkyotex Sa Amido thiazole derivatives as NADPH oxidase inhibitors
CA3017366A1 (en) * 2016-03-11 2017-09-14 H. Lee Moffitt Cancer Center And Research Institute, Inc. Icariin and icaritin derivatives
WO2018107689A1 (zh) * 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 一种预防和治疗脂质肾损伤的方法
CN108210915A (zh) * 2016-12-15 2018-06-29 深圳瑞健生命科学研究院有限公司 改善心脏病变的药物及其用途
TW201822812A (zh) * 2016-12-15 2018-07-01 深圳瑞健生命科學硏究院有限公司 一種預防和治療肥胖症的方法
US11389515B2 (en) 2016-12-15 2022-07-19 Talengen International Limited Method for mitigating heart disease
CA3047181A1 (en) 2016-12-15 2018-06-21 Talengen International Limited Method and drug for preventing and treating obesity
CN106822087A (zh) * 2017-01-12 2017-06-13 西南大学 香叶木素在制备治疗ⅱ型糖尿病的药物中的应用
CN109280067B (zh) * 2017-07-21 2022-07-05 南京正大天晴制药有限公司 香叶木苷衍生物、其制备方法以及医药用途
EP3479843A1 (en) 2017-11-01 2019-05-08 GenKyoTex Suisse SA Use of nox inhibitors for treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701261B1 (fr) * 1993-02-05 1995-03-31 Adir Nouveaux composés glucuronides de la diosmétine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
FR2726273B1 (fr) * 1994-10-26 1996-12-06 Adir Nouveaux derives de la diosmetine, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2748025B1 (fr) * 1996-04-25 1998-10-30 Adir Nouveaux acides et esters de la diosmetine, et les compositions pharmaceutiques les contenant
US6538021B1 (en) * 1998-10-30 2003-03-25 Merck Patent Gesellschaft Method for producing luteolin and luteolin derivatives

Also Published As

Publication number Publication date
ZA200707472B (en) 2008-11-26
EP1853253A1 (fr) 2007-11-14
MA29316B1 (fr) 2008-03-03
WO2006092490A1 (fr) 2006-09-08
FR2882654B1 (fr) 2007-04-27
CA2599658A1 (fr) 2006-09-08
EA200701820A1 (ru) 2008-02-28
KR20090128581A (ko) 2009-12-15
BRPI0607562A2 (pt) 2009-09-15
US20080176934A1 (en) 2008-07-24
MX2007010364A (es) 2007-09-25
NZ560749A (en) 2010-11-26
KR100971589B1 (ko) 2010-07-20
NO20074941L (no) 2007-10-01
AR053149A1 (es) 2007-04-25
CN101132788A (zh) 2008-02-27
JP2008531660A (ja) 2008-08-14
FR2882654A1 (fr) 2006-09-08
AU2006219853A1 (en) 2006-09-08
EA013078B1 (ru) 2010-02-26
AU2006219853B2 (en) 2011-06-09
KR20070110395A (ko) 2007-11-16

Similar Documents

Publication Publication Date Title
UA91848C2 (ru) Применение соединений диосметина в лечении и предотвращении тромботическим патологиям
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
EA200870019A1 (ru) Лактамовые соединения и способы их применения
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
IL191057A0 (en) Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies
ZA200801706B (en) Methods and compositions for the prevention and treatment of kidney disease
DK1962873T3 (da) Farmaceutiske sammensætninger omfattende oxalat-reducerende bakterier
ATE484194T1 (de) Wirkstoffkombinationen
EA200970483A1 (ru) Применение пролекарств габапентина и прегабалина для лечения шума в ушах
ZA200800452B (en) Methods and compositions for the prevention and treatment of kidney disease
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
ZA200708819B (en) Methods and compositions for the prevention and treatment of kidney disease
CY1111762T1 (el) Διενυδρη παμοϊκη ολανζαπiνη
EP1905452A4 (en) AGENT FOR THE PREVENTION OR TREATMENT OF GLAUCOMA
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
ITRM20050446A1 (it) Uso di stilbeni idrossilati e glucosidati per la prevenzione ed il trattamento di patologie oculari.
CL2005003456A1 (es) Proceso de preparacion del beta-anomero enriquecido de clorhidrato de gemcitabina; compuesto intermediario involucrado en dicho proceso; y su proceso de preparacion.
PT1858481T (pt) Composições oftalmológicas e sua utilização
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
IL186851A0 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
BRPI0511165A (pt) uso de sulglicotìdeo
DE112006002041A5 (de) Pharmazeutisch wirksame Zusammensetzung zur Behandlung von Diabetes
EA200801023A1 (ru) Применение фенофибрата или его производного для предотвращения диабетической ретинопатии
WO2008140577A3 (en) Cd44 pathway antagonists for treatment of adenoviral infection